• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Veradigm and Healthverity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes

Share:

February 21, 2023

What You Should Know:

– Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem.

– The HealthVerity IPGE platform is an integrated technology and real-world data (RWD) infrastructure that allows disparate data to be accurately resolved to unique privacy-protected identities, then linked in a HIPAA-compliant manner and exchanged for a myriad of use cases.

– By connecting Veradigm’s Cardiology and Metabolic registries with broad-scale healthcare and consumer data from HealthVerity, the collaboration provides clinical researchers with unique access to regulatory-quality, HIPAA-compliant and research-ready data to advance analytics and treatments for these prevalent conditions.

Veradigm Cardiology Registry

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The Veradigm Cardiology Registry is the largest U.S. outpatient cardiovascular quality improvement registry, with 102+ million records, representing 18.9+ million unique patient lives, 13,000 providers and 4,000 office locations. The registry captures data on coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), hypertension (HTN) and peripheral arterial disease (PAD). It follows cardiac patients across their journey, tracking key measures, including patient demographics, plan of care, cardiac events and comorbidities, exams, procedures, lab values, related medications, and more.

The Veradigm Metabolic Registry is the first clinical ambulatory registry aimed at tracking and improving the quality of prediabetes, diabetes, and cardiometabolic care across the primary and specialty care continuum. The registry has 79+ million records, representing 13.5+ million unique patient lives, 11,100 providers, and 3,400 office locations. Key measures captured include patient demographics, A1c control, nephropathy, blood cholesterol, hypertension eye exam, foot exam, antiplatelet therapy and more. Additionally, Veradigm’s electronic health record (EHR) data from the most recent five years is incorporated, representing over 176 million patients with clinical activity, as well as Veradigm medical claims and remittance data for 300 million medical claims captured in a rolling two-year period.

“Veradigm provides life science researchers scalable access to real-world clinical data via our direct connection with the point-of-care,” said Stuart Green, Senior Vice President and General Manager, Veradigm. “With Veradigm’s Registry and EHR data on the HealthVerity platform, we are extending the reach of the Veradigm Network to further support improvements in patient care at scale.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Goldcup 34064 AB Announces Vironova BioAnalytics Acquired by Investor GroupGoldcup 34064 AB Announces Vironova BioAnalytics Acquired by Investor Group
  • Why SDoH Data is Key for Developing Population Health StrategiesWhy SDoH Data is Key for Developing Population Health Strategies
  • MedEquities Stockholders Approve Merger With Omega Healthcare InvestorsMedEquities Stockholders Approve Merger With Omega Healthcare Investors
  • Finding unconventional sources of capital in the face of revenue pressuresFinding unconventional sources of capital in the face of revenue pressures
  • Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine PlatformRapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform
  • Blockchain’s Biggest Potential in HealthcareBlockchain’s Biggest Potential in Healthcare
  • Yale, Sharecare Partner for an Online Physician Assistant Curriculum, CoxHealth Adopts MDLive’s Platform and More Digital Health DealsYale, Sharecare Partner for an Online Physician Assistant Curriculum, CoxHealth Adopts MDLive’s Platform and More Digital Health Deals
  • KeyHIE, Life Image First in Nation to Implement FHIR-Based Imaging App to Share Diagnostic Content in Provider PortalKeyHIE, Life Image First in Nation to Implement FHIR-Based Imaging App to Share Diagnostic Content in Provider Portal

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications